We discuss ipi/nivo combination therapy versus VEGF TKI I/O immune therapy for ccRCC with Mike Atkins, MD.
Dr. Atkins serves as Scholl Professor and Vice Chair of the Department of Oncology at Georgetown University.
Episode 249: ASCO 2023 - IPI/NIVO vs VEGF/PD1 in Kidney Cancer With Mike Atkins
By The Uromigos - Last Updated: June 21, 2023
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.